The Drosophila heart has emerged as a powerful model system for cardiovascular research. This simple organ, composed of only 104 cardiomyocytes and associated pericardiac cells, has been the focus of numerous candidate gene approaches in the last 2 decades, which have unraveled a number of transcription factors and signaling pathways involved in the regulation of early cardiac development. Importantly, these regulators seem to have largely conserved functions in mammals. Recent studies also demonstrated the usefulness of the fly circulatory system to investigate molecular mechanisms involved in the control of the establishment and maintenance of the cardiac function. In this review, we have focused on how new technological and conceptual advances in the field of functional genomics have impacted research on the cardiovascular system in Drosophila. Genome-scale genetic screens were conducted taking advantage of recently developed ribonucleic acid interference transgenic lines and molecularly defined genetic deficiencies, which have provided new insights into the genetics of both the developmental control of heart formation and cardiac function. In addition, a comprehensive picture of the transcriptional network controlling heart formation is emerging, thanks to newly developed genomic approaches which allow global and unbiased identification of the underlying components of gene regulatory circuits.
INTRODUCTION
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(stages 9 and 10) that will give rise to both visceral and cardiac musculature. A decapentaplegic (Dpp)/ TGFb signal from the dorsal ectoderm plays an instrumental role in this process. The cardiac mesoderm is then specified in these dorsal most mesodermal cells (stage 11), through the action of intrinsic transcription factors (TFs) Tinman (Tin), Dorsocross (Doc), Pannier (Pnr) and ectodermderived signaling pathways Wingless (Wg) and Dpp. Subsequent steps also depend on both intrinsic factors and continuous signaling from the ectoderm ( Figure 1C ) [5] , leading to cardioblast specification and their progressive diversification (stage 12) and differentiation. The latter occurs during dorsal closure (stages [13] [14] [15] and culminates in the formation of the cardiac tube, by dorsal migration of the Figure 1 : The Drosophila heart. (A) Schematic picture of the embryonic/larval cardiac tube anatomy (dorsal view). The anterior part (aorta) is morphologically distinct from the posterior (heart) region. Cardioblasts (CB) are sub-divided into seven-up (svp) -expressing CB, which differentiates into ostiae (inflow tracts) in the heart, and tinman (tin) -expressing cardioblasts. A pair of tin CB differentiates into valve-like cells, forming the boundary between the aorta and the heart proper. Pericardiac cells (PC) and lymph gland cells (LG) are schematized. Dotted arrows illustrate the flow of hemolymph within the organ. (B) Sagittal view of a Drosophila larva showing the dorsal position of the cardiac tube. (C) Embryonic cardiac gene regulatory network drawn from data in the literature. Interactions of the molecular components driving the specification of cardiac cells are depicted from the bottom to the top with the corresponding embryonic stages (see [5] for details) on the right. Positive and negative regulatory events are represented by arrows and bars, respectively. See text for details.
cardiomyocytes which eventually meet at the dorsal midline.
Since the identification of the first Drosophila cardiogenic gene tinman (tin) [6] [7] [8] that led to the cloning of the mouse Nkx2-5 gene [9, 10] , also involved in cardiogenesis, many genes controlling heart development have been shown to be conserved from flies to mammals. Importantly, not only are most TFs and signaling pathways involved in invertebrates cardiogenesis also required for vertebrate heart development but also their respective organization within the cardiac gene regulatory network (GRN) appears to be similar [11, 12] . This homology seems to extend far beyond these developmental aspects. Indeed, genetics of cardiac function and aging in Drosophila have revealed that the control of cardiac physiology and rhythmicity is conserved in multiple ways between vertebrates and invertebrates [13] [14] [15] [16] [17] [18] [19] . Therefore, although much simpler in its cellular organization and morphology, the fly cardiac system has emerged as a model of choice to dissect the genetic control of cardiac development and function.
A decisive advantage of Drosophila cardiogenesis is its relative simplicity. The cardiac tube is formed by a small number of myocytes, which can be individually identified in vivo, allowing analyses at single cell resolution. Therefore, the emergence of the specific physiological properties associated with the genetic diversification of the cells as well as the ultimate fate of each cell can be followed during the whole developmental process. In addition, the mature organ is localized dorsally just under the cuticle ( Figure 1B ), thus facilitating in vivo analysis of its activity. Furthermore, heart function is not required for oxygen transport, which in arthropods is ensured by the tracheal system and, therefore, cardiac activity appears dispensable for viability both in larvae [13] and in adults (our unpublished data and [14] ). Consequently, analysis of essential genes for heart function is feasible, thanks to the available tools enabling spatial and temporal targeted gene expression or gene inactivation by ribonucleic acid interference (RNAi). These features have allowed extensive progress to be made in the last two decades in unraveling the function of various TFs, signaling pathways and cell biological processes important both for heart organogenesis and the acquisition and maintenance of its function.
Our goal in this study is to review primary research exploiting the power of Drosophila genetics and genomics at a genome-wide scale to investigate cardiogenesis. This includes genetic screens aimed at understanding both the genetic control of heart formation in the embryo and functional/physiological aspects of the mature organ, in particular as a model for human cardiovascular diseases. Data-driven transcriptomic and chromatin immunoprecipitation (ChIP) approaches to analyze the cardiac GRN are also reviewed. As we focus on genome-wide approaches, a large number of studies are not included, and we apologize to those whose work is not cited. Other aspects of cardiogenesis in flies have recently been discussed in several reviews that the reader is invited to consult [3, 14, 15, [19] [20] [21] .
GENETIC APPROACHES Cardiogenesis
Historically, the identification of genes involved in the regulation of cardiogenesis in the fly has relied essentially on candidate gene approaches. In the last decade, however, the field has greatly benefited from large-scale genetic screens. A pioneering study [22] described an RNAi-based genome-scale loss of function screen for cardiogenic genes. Taking advantage of a b-galactosidase reporter reproducing cardiacspecific expression of Mef2, more than 5800 genes (40% of the fly's predicted genes set) were screened for heart mutant phenotypes by injection of doublestrand RNA (dsRNA) in the developing embryo. This high-throughput monitoring of heart morphology in embryos leads to the identification of 132 genes, including genes encoding TFs and cell signaling molecules, directly or indirectly involved in different steps of cardiac development.
More recently, two genetic screens for mutants presenting heart defects were conducted in transgenic lines harboring a green fluorescent protein (GFP), which allows direct examination of mutant phenotypes in live embryos. Schultz and coworkers [23, 24] screened for genes required for embryonic heart development using both Toll and Hand cardiacspecific enhancers. The Toll-GFP transgene expresses GFP in cardioblasts from stage 12 onward, whereas Hand-GFP is expressed in all cell types of the dorsal vessel, including cardioblasts, pericardial cells and the lymph glands ( Figure 1A ). Screening genetic deficiencies covering the second chromosome (40% of the genome) and focusing on regions required for generating the proper number of cardioblasts or affecting the morphology of the mature organ, they identified eight genes involved in cardiogenesis [25] . A number of those have vertebrate homologs, and some of them are known to be involved in cardiogenesis in mammals. This is, in particular, the case of tailup (tup), related to the mammalian LIM TF encoding gene Islet-1. tailup was further shown to be required for specification of both cardioblasts and lymph gland cells [26] , thus revealing a central role for this gene in the cardiac GRN, a function also pointed out by Mann et al. [27] ( Figure 1C) . The second genetic screen was conducted by the Olson and coworkers [28] , where a collection of 3000 P transposon-mediated mutations were screened for cardiac abnormalities in which pericardiac and cardiac cells dissociate, using the Hand-GFP transgenic line. This leads to the identification of the mevalonate pathway as being involved, within cardioblasts and by post-translational modification of the G protein 1, in cell migration and/or cell-cell adhesion during cardiac tube formation.
King etal.
[29] used a radically different strategy to screen the fly genome for genes interacting with the micro-RNA (miR)-1, whose function is required for developing and maintaining somatic and cardiac muscles in both flies [30, 31] and mice [32, 33] . Using the patterning of the adult wing as a sensitive assay for identifying modifiers of a gain of function phenotype induced by targeted miR-1 overexpression, they have screened genomic deletions covering 70% of the fly genome. They identified kayak (kay), the Drosophila c-Fos ortholog, as genetically interacting with miR-1 and showed that kay is regulated by miR-1. In the cardiac tube, both were identified as being involved in the modulation of cardiac cell polarity. Additionally, c-Fos was shown to be deregulated in hearts mutant for miR-1 in mice, highlighting the conservation of this pathway.
Cardiac function
The conservation of cardiogenesis from flies to humans, which extends from conserved molecular mechanisms that orchestrate heart formation to conserved gene functions required for maintaining normal heart physiology, has prompted a number of studies using the Drosophila heart as a platform to identify genes and pathways potentially involved in cardiovascular diseases. Different functional assays have been developed to monitor cardiac performances in fly, allowing medium to high-throughput screening for genes involved in cardiac function and aging.
We recently demonstrated that the larval cardiac tube senses mechanical forces and responds by regulating cardiac activity, providing a simple in vivo system to screen for genes involved in mechanotransduction. A pilot genetic screen, based on cardiactargeted gene inactivation by RNAi and focused on ion channel encoding genes, revealed a central role for the transient receptor potential gene painless (pain) in the process, validating the approach and opening new avenues for understanding the mechanisms underlying a mechanotransduction pathway [34] .
In the laboratory of Bodmer, functional assays have been developed to monitor cardiac activity and stress resistance in adult flies. In particular, it was shown that controlled electrical pacing can induce heart arrests and that recovery of the heart activity depends on the age of the individuals and is influenced by a number of genetic factors, including well-known members of the cardiac GRN, such as tin, which are also involved in maintaining cardiac function [35] . This allowed the development of large-scale genetic screens. In addition, a method for detecting and quantifying heart beat parameters on dissected adults was developed, allowing precise measurement of heart rate, rhythmicity and contractility [36] .
To identify new genes with critical roles in adult cardiac function that cooperate with known cardiac determinants, Qian et al. [35] screened genomic deletions covering 34% of the fly genome for enhancement of the cardiac stress response to electrical pacing of flies heterozygous for tin loss of function. They identified the small RhoGTPase Cdc42 among tin interactors. This genetic interaction is further supported by the observation that flies lacking one copy of both genes (tin-Cdc42 double heterozygotes) present a strong increase of arrhythmias and lower heart rate compared with single heterozygotes. Additional investigations suggested that tin and Cdc42 interact to regulate heart function through the activation of the K þ channels dSur and slowpoke. Importantly, the authors show that the synergistic interaction between tin and Cdc42 is conserved in mammals, as Nkx2-5 and Cdc42 double heterozygous mice also present impaired cardiac function, characterized by conduction system and cardiac output defects. Moreover, this study identifies the mouse Cdc42 gene as a direct target of miR-1, which is itself negatively regulated by Nkx2.5 in mice and by tin in Drosophila. Cdc42 thus seems to play a conserved role in regulating cardiac function and to be an indirect target of tin/Nkx2.5 by miR-1. In another study [37] , Drosophila was used as a model to identify genetic interactions contributing to polygenic diseases, focusing on a small region mapped to the tip of the human chromosome 21, which contributes to congenital heart defect in Down syndrome. The effect of the overexpression of six gene candidates and of their Drosophila homologs either individually or in all possible pairwise combination specifically in adult cardiac cells was evaluated by measuring heart functional parameters. The same strategy was undertaken using the developing eye, a widely used assay system for genetic interaction in Drosophila, as an alternative model tissue, and the results were combined to evaluate the consistency and strength of the unraveled interactions. Using this approach, a novel interaction between the transmembrane protein adhesion DSCAM (Down Syndrome Cell Adhesion Molecule) and the extracellular matrix component COL6A2 (alpha 2 subunit of type VI collagen) was identified and shown to be conserved in mouse, validating the usefulness of Drosophila as a platform to systematically test genetic interactions related to cardiac disease.
An alternative method for evaluating cardiac function in adult flies, optical coherence tomography (OCT), was developed in the Wolf and Rockman laboratory [38] . Similar to echocardiography in humans, it allows monitoring of cardiac parameters, including heart tube diameters at diastole and systole, in intact individuals, thus permitting high-throughput screening for cardiac performance. Using OCT, Yu et al. [39] screened for molecularly defined deficiencies along the Drosophila chromosome 3L that induce function abnormalities in the adult heart. Deficiency mutants spanning the Rhomboid 3 (Rho3) locus, encoding a transmembrane protein required for the processing of a critical Epidermal Growth Factor (EGF) receptor ligand, cause heart dilatation. This dilated cardiomyopathy phenotype is specific to the maintenance of adult cardiac function as no developmental abnormalities are observed in homozygote mutants. Expression of an activated form of EGF receptor or of its processed ligand in adult cardiac cells rescues the dilated heart phenotype caused by Rho3 loss of function, whereas expression of a dominant negative form of the EGF receptor in the same cells induces a dilated cardiomyopathy phenotype. Of interest, previous studies demonstrated that inhibiting the EGF receptor ErbB2 in mouse and humans also causes dilated cardiomyopathies. This suggests that the maintenance of post-developmental cardiac function in Drosophila and vertebrates requires an active EGF receptor.
The same strategy was used to screen genetic deficiencies along chromosome 2L [40] and identified a novel Notch ligand (CG31665, named weary) as causing dilated cardiomyopathies, thus pointing to a critical role of the Notch pathway for the maintenance of normal heart function. In yet another screen focused on chromosome X [41] , an uncharacterized Drosophila gene, CG3226, was identified for causing dilated cardiomyopathy. CG3226 is homologous to the mammalian Siah-interacting protein (SIP), a member of a multiprotein complex that regulates b-catenin levels, pointing to a potential role of SIP/b-catenin in the control of heart size and function. Thus, these genome-scale genetic screens illustrate the usefulness of the Drosophila model to identify genes and pathways responsible for dilated cardiomyopathies.
Recently, an attempt to provide a systems level understanding of the genes and pathways playing conserved roles in the cardiovascular system was conducted. To comprehensively identify such genes and pathways, Neely etal. [42] carried out a genome-wide in vivo RNAi screen, in which 7061 Drosophila genes with conserved mammalian homologs were inactivated in the fly heart. A total of 498 genes were identified that cause either developmental lethality or decreased survival at adulthood under temperature stress. From this gene set, data mining and bioinformatics analysis, taking into account protein-protein interactions data available in both fly and mammals, allowed a global gene network regulating heart function to be drawn up. This data-driven approach highlighted a number of functional categories and pathways overrepresented in the gene set. Among this global roadmap of essential components potentially involved in heart function, the authors identified the NOT-CCR4 complex implicated in transcriptional and post-transcriptional regulatory mechanisms, as a conserved regulator of heart function in both fly and mice, and further showed that in humans a single-nucleotide polymorphism in the NOT3 gene correlates with altered cardiac rhythm.
This study illustrates the power of global datadriven approaches based on unbiased genome-wide functional genomic investigations, which allow comprehensive knowledge acquisition of the process from which a global picture can be drawn up, as opposed to approaches based on a priori hypotheses. It also demonstrates that a functional genome-wide screen in Drosophila can identify candidate genes involved in heart function in mammalian species. Indeed, model systems of human heart diseases are necessary to facilitate the screening and identification of genes and genetic variations that either cause or influence the development and progression of these diseases. However, in mammals, experiments aimed at identification of genes and genetic interactions involved in cardiomyopathies and cardiac diseases are far more complex to conduct, due to genetic redundancy, complexity of available genetic tools and long life span. In Drosophila, methodological advances have permitted accurate characterization of conserved regulators of cardiac morphology and function. The short literature survey presented in this study demonstrates that these methodological advances, combined with the plethora of tools available to analyze fly genetics at the genome scale, facilitate gene discovery and usefully complements mammalian models of cardiac diseases. In addition, Drosophila has emerged as a model of choice for screening for drugs that modify cardiac activity, and this can usefully complement genetic and genomic approaches [43] [44] [45] . Different studies in several laboratories are currently under way to further analyze cardiac function and its maintenance, notably during aging. These investigations, a number of which are based on state of the art genomic approaches, will undoubtedly contribute to providing further insights into human cardiac biology.
Genomic approaches to analyzing cardiac GRNs
A traditional way to study organogenesis consists of focusing analysis on discrete genes or to simple gene networks, to evaluate their function in the development of particular cells within the organ. However, because of the complexity of organogenesis, acquiring a comprehensive knowledge of these processes through candidate gene approaches seems to be a long-term goal. Moreover, one would like to obtain a global view of organogenesis in which the temporal and spatial cues are integrated into a unique picture. Functional genomics now allows comprehensive identification of tissue-specific expression profiles. From this information, datadriven approaches can be conducted to decipher the molecular pathways involved. In addition, genome-wide identification of cis-regulatory modules (CRMs) bound by TFs through ChIP-Chip or ChIP-seq experiments can greatly enhance our comprehension of the developmental GRNs driving cell-specific patterns of gene expression. In particular, comprehensive identification of direct targets of TFs that are dynamically regulated over time is not only essential to understand the biological function of these TFs but will also contribute to our understanding of the logical wiring of the networks.
An integrated strategy, combining genomic and reverse genetic analysis, was developed in our laboratory to comprehensively determine the molecular pathways that participate in Drosophila adult heart organogenesis [46] . The adult dorsal vessel is built from the same cardioblasts as in the larva, which are reprogrammed during metamorphosis to adopt the characteristics of the adult heart [47] [48] [49] . A precise molecular portrait of adult heart formation was drawn using whole-genome analysis of the temporal dynamics of heart-specific gene expression. Strikingly, this temporal map of gene expression revealed tight transcriptional regulation of key components of a small number of signaling pathways. By reverse genetics, we demonstrated that these are implicated in discrete steps of heart organogenesis. In particular, the Wg/Wnt signaling pathway is involved in adult ostia (inflow tracts) formation and adult cardiac myocytes differentiation, whereas activation of Vascular Endothelial Growth Factor/ Platelet-Derived Growth Factor (VEGF/PDGF) signaling is required for cardiac valve formation. Interestingly, the VEGF pathway was independently shown to participate in valve formation in mammals. In this study, dynamic gene expression in the heart was investigated by dense sampling of time points and a high number of biological and technical replicates. This strategy allows construction of a detailed and accurate temporal map of gene expression and furnishes significant new insights into the signaling pathways involved in heart organogenesis. Furthermore, this study emphasizes that data-driven approaches, integrating genomic and reverse-genetics, are an efficient way to provide comprehensive knowledge of an organogenesis process.
Regarding the analysis of the cardiac GRN at a global level, the first cell-type-specific genome-wide analysis of cell specification in the cardiac and muscular tissues focused on one TF and was carried out in the Jagla laboratory by Junion et al. [50] . The control of cell diversification and differentiation by ladybird (lb) was investigated from stages 9 to 15. lb downstream targets were identified by differential transcriptome analysis of embryos with tissue-targeted lb loss and gain of function, and direct targets were identified using ChIP-chip. These experiments revealed that lb acts at multiple levels and controls a complex and dynamic gene network comprising not only cell identity genes (such as TFs) but also realisator genes that directly impinge on morphogenesis and the acquisition of function in cardiac precursor cells.
More recently, a comprehensive identification of CRMs bound by cardiogenic TFs was performed in the Furlong laboratory [51] and revealed a number of insights into the regulatory control of cardiac specification in the context of the developing embryo. ChIP-chip experiments were performed for three cardiac TFs, Pnr, Doc and Tin, and Mothers against Dpp (Mad) and pangolin/dTCF. The last two are transcriptional effectors of Wg/Wnt and Dpp pathways, the main signaling cascades regulating cardiac specification ( Figure 1C ). Embryos were analyzed at two successive developmental time windows (stages 8/9 and 10/11), corresponding to the specification of the dorsal mesoderm and its subsequent specification into cardiogenic and visceral mesoderm (VM). Among all five TFs, only Tin expression is limited to the mesoderm; analysis was, therefore, restricted to CRMs that were bound at least by Tin, the majority of which also recruited other factors. Interestingly, it was shown that the five TFs bind cooperatively to these enhancers, a large proportion of which driving expression in cardiogenic mesoderm. The TFs seem to be recruited as a collective unit, the occurrence of binding of all five TFs being much more frequent than any other combination. In addition, it was demonstrated that all five TFs must be present for maximal enhancer activity. Surprisingly, although a statistical enrichment for Docand Pnr-binding sites was found at these enhancers, this was not true for the other TF-binding sites. This demonstrates that binding sites arrangement along the enhancers is highly flexible and suggests that cardiogenic TFs are recruited and activate enhancers with little cis-regulatory motives grammar. Unexpectedly, a significant proportion of CRMs bound by the five cardiogenic TFs were active in the VM but not in the cardiogenic mesoderm. These enhancers were shown to be also bound by the FoxF TFs Biniou in the VM or by sloppy paired in the cardiac mesoderm. Importantly, those CRMs could be rendered active in the heart following mutation of the FoxF-binding sites. This TF-binding signature may unravel lineage history of these cells as both cardiac and visceral cells are derived from the dorsal mesoderm.
One of the main limitations in analyzing the embryonic cardiac GRN with the approaches mentioned earlier was the lack of spatial definition in the methods used. Indeed, cardiomyocytes represent less than 1% of the whole embryo cell population, and one would like to identify cardiac-specific transcripts, as well as the TF-binding landscape, in a tissue-specific manner. Novel methods have been developed that should allow attaining these goals. Two recent reports described the isolation of cardiac cells from Drosophila embryos based on fluorescent-activated cell sorting, allowing the analysis of the cardiac transcriptome of Drosophila at distinct stages of embryonic development ( [52] and our unpublished data) and the identification of cardiac-specific alternatively spliced transcripts [53] . In addition, two alternative methods have been published for tissue-specific nuclei purification, opening new avenues for tissue-specific analysis of chromatin marks and TF-binding activities [54, 55] .
CONCLUSION
In the past few years, one of the major advancements in the field has come from the development of largescale forward genetic screens, which have allowed the unbiased identification of genes involved in both embryonic cardiogenesis and the establishment and maintenance of heart function. Continuous efforts along these lines will further unravel the genetic control of cardiac development and function. Furthermore, the development of novel methodologies and data, such as the determination of the cardiac-specific proteome [56] , should usefully complement these high-throughput mutagenesis screens and provide a holistic knowledge of these processes. In addition, comprehensive analysis of transcriptome and TFs binding landscape now allow non-biased, data-driven approaches to explore the cardiac GRN during embryogenesis. In the near future, the availability of large-scale data sets should allow modeling of the underlying GRNs and provide broad insight into the downstream events that progressively drive cardiac cell diversification and differentiation.
Key Points
The fly heart is a simple but valuable model to analyze cardiogenesis and investigate the genetic and molecular basis of cardiomyopathies. Recent genome-scale genetic screens and functional genomic approaches of cardiogenesis in fly are reviewed. Data-driven approaches open new avenues to a comprehensive understanding of the cardiac GRN driving cardiogenesis and of cardiac function in the mature organ. Evolutionary conservations of these processes between flies and vertebrates are highlighted.
